Pathogen Rna Quantification
Pathogen Rna Quantification - Related Videos
10:39
Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
0 Views •
Cited by 40 •
2016
This protocol describes the isolation and quantification of high-density lipoprotein small RNAs.
07:58
Use of Image Cytometry for Quantification of Pathogenic Fungi in Association with Host Cells
0 Views •
Cited by 1 •
2013
Here, we demonstrate how image cytometry can be used for quantification of pathogenic fungi in association with host cells in culture. This technique can be used as an alternative to CFU enumeration.
02:12
Co-Infiltration Assay for Screening Pathogen Effectors that Suppress Plant RNA Silencing
0 Views •
2026
Source: Shi, J., et al. Screening and Identification of RNA Silencing Suppressors from Secreted Effectors of Plant Pathogens. J. Vis. Exp. (2020)This video demonstrates a co-infiltration assay for identifying pathogen effector proteins that suppress RNA silencing in Nicotiana benthamiana 16c. A fluorescent reporter and a candidate effector gene are delivered into plant leaves via Agrobacterium. Normally, RNA silencing degrades reporter transcripts, reducing fluorescence. Suppressor effectors...
10:52
Visualization and Quantification of Intermolecular RNA Base Pairing in in vitro RNA Clusters Using Split Broccoli RNA Reporters
0 Views •
2026
This protocol describes a visual assay using split Broccoli RNA reporters to detect and quantify intermolecular base pairing in RNA clusters in vitro.
06:02
A Computational Pipeline for Intergenic/Intragenic Enhancer RNA Quantification in Mouse Embryonic Stem Cells
0 Views •
2025
This protocol provides a streamlined computational pipeline for quantifying nascent enhancer transcripts. By integrating chromatin accessibility, chromatin feature, and transcriptional data, it enables accurate detection and strand-specific analysis of enhancer activity in complex intragenic regions, while remaining accessible to researchers without extensive bioinformatics training.
FAQs
Reverse transcription converts pathogen RNA into complementary DNA, creating a template that the amplification system can process. This step is essential because the subsequent sequence-specific amplification and fluorescence detection depend on the resulting complementary DNA rather than directly measuring RNA during amplification. Its role connects the original RNA signal in the sample to the cycle-based measurement used for comparison.
During sequence-specific amplification, each cycle generates additional detectable product, and fluorescence increases as the amplified signal accumulates. The cycle-threshold value records when that signal reaches the assay’s detection threshold. Because signal development relates to the starting template, cycle-threshold values can support comparisons of pathogen RNA levels when the assay and sampling conditions are controlled.
A cycle-threshold value is interpretable for comparison only when measurements come from controlled assay and sampling conditions. Differences in how samples are obtained or how the assay is applied can influence the measured signal independently of pathogen RNA levels. Consistent conditions therefore help researchers distinguish changes associated with infection from variation introduced by measurement procedures.
The workflow first uses reverse transcription to convert pathogen RNA into complementary DNA. The resulting template then undergoes sequence-specific amplification, while fluorescence provides a signal that increases with amplification. Researchers interpret the cycle-threshold result in relation to the starting template and compare measurements only across appropriately controlled samples and assay conditions.
Repeated measurements can show how pathogen RNA levels change over time, allowing investigators to examine patterns during infection or after treatment begins. The same measurements can be considered alongside host responses to assess how pathogen material and immune-related changes relate to one another. Such comparisons are most informative when sampling and assay conditions remain consistent.
In immunology and infection research, pathogen RNA quantification can support monitoring across time, evaluation of treatment or host responses, and investigation of transmission. It can also be applied to environmental samples when researchers need to assess pathogen-derived RNA outside a clinical specimen. These uses extend the method from individual infection studies to broader pathogen surveillance questions.